Sept 25 (Reuters) – The US Food and Drug Administration has approved AbbVie's drug for Parkinson's disease in adults, the health regulator's website showed on Friday. (Reporting by Kamal Choudhury in
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
* Colombia October inflation edges up to 6.3% * Mexican shares set to snap 5-session…
Nov 10 (Reuters) - Mercor said on Tuesday it had raised $750 million in a…
Nov 10 (Reuters) - Mercor said on Tuesday it had raised $750 million in a…
Nov 10 (Reuters) - Pengo Holdings Group Ltd: * ENTERS LETTER OF INTENT ON COOPERATION…
Nov 10 (Reuters) - Kimou Environmental Holding Ltd : * UNIT, OTHER ENTERS CONSTRUCTION CONTRACTS…
By Lucia Mutikani WASHINGTON, Nov 10 (Reuters) - US consumer prices increased more than expected…